5 minute read
Sep. 26, 2023

A Clinical, Oral, Cell-Penetrant, Reversible, Macrocyclic Peptide Pan-RAS Inhibitor from mRNA Display


oral KRAS inhibitor Ph. I dose-escalation for metastatic solid tumors from mRNA display library hit J. Am. Chem. Soc., July 18, 2023 Chugai, Yokohama, JP


Molecules of the Month - July 2023

MOTY Nominees

Molecule of the Year